August 13, 2021
RegMed Investors’ (RMi) pre-open: TGIF, a winning market high week with a split 2 positive by 2 negative sector closes
August 12, 2021
RegMed Investors’ (RMi) pre-open: Low volume and declining breadth infects the cell and gene therapy sector
August 11, 2021
RegMed Investors’ (RMi) pre-open: how do you know, what will happen today if you don’t have a handle on yesterday
August 10, 2021
RegMed Investors’ (RMi) pre-open: says who and what, facts and supporting numbers need to validate opinion
August 9, 2021
RegMed Investors’ (RMi) pre-open: the earnings’ LPS (loss-per-share) keep coming
August 6, 2021
RegMed Investors’ (RMi) pre-open: safety is protecting from or not exposed to danger or risk
August 5, 2021
RegMed Investors’ (RMi) pre-open: the hall of mirrors continues with earnings the focus
August 4, 2021
RegMed Investors’ (RMi) pre-open: watch your “six”
August 3, 2021
RegMed Investors’ (RMi) pre-open: earnings, LPS or loss-per-share and the need to know
August 2, 2021
RegMed Investors’ (RMi) pre-open: ready or not, earnings could cause more declines
July 30, 2021
RegMed Investors’ (RMi) pre-open: feelin’ the squeeze as July ends on a sour note
July 29, 2021
RegMed Investors’ (RMi) pre-open: key word, sustainability
July 29, 2021
RegMed Investors’ (RMi) pre-open: key word, sustainability
July 28, 2021
RegMed Investors’ (RMi) pre-open: when and where are the bounces for the oversold?
July 27, 2021
RegMed Investors’ (RMi) pre-open: slippage, drippage or both
July 26, 2021
RegMed Investors’ (RMi) pre-open: last trading week of July and closer to sector Q2 earnings’ releases
July 23, 2021
RegMed Investors’ (RMi) pre-open: TGIF
July 22, 2021
RegMed Investors’ (RMi) pre-open: my internal Ouija board has lost its spirit
July 21, 2021
RegMed Investors’ (RMi) pre-open: algorithms could hack share pricing upsides
July 20, 2021
RegMed Investors’ (RMi) pre-open: recognition for the oversold or as good as it can get
July 19, 2021
RegMed Investors’ (RMi) pre-open: sector woes follow markets weakness
July 16, 2021
RegMed Investors’ (RMi) pre-open: wrapping a demoralizing share pricing week for the cell and gene therapy sector
July 15, 2021
RegMed Investors’ (RMi) pre-open: sector flounders with no news
July 14, 2021
RegMed Investors’ (RMi) pre-open: caution as jittery sentiment wraps markets yet our sector could feel an oversold jolt
July 13, 2021
RegMed Investors’ (RMi) pre-open: ricochet as sector struggles?
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.